Trials / Unknown
UnknownNCT05423964
Impact of AI on Trainee ADR
Impact of Artificial Intelligence on Trainee Adenoma Detection Rate
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- University of Southern California · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Adenoma detection rate (ADR) is a validated quality metric for colonoscopy with higher ADR correlated with improved colorectal cancer outcomes. Artificial intelligence (AI) can automatically detect polyps on the video monitor which may allow endoscopists in training to improve their ADR. Objective and Purpose of the study: Measure the effect of AI in a prospective, randomized manner to determine its impact on ADR of Gastroenterology trainees.
Detailed description
Our objective is to determine the impact of AI on the adenoma detection rate of Gastroenterology trainees. The secondary aim of this quality improvement study is to determine the impact of AI based endoscopy on the rate of recording of quality improvement metrics versus historical performance in our program. Fellows will undergo educational session prior to the start of study, describing commonly used metrics for assessing quality of colonoscopy and how to use the artificial intelligence software. Gastroenterology fellows will be consented for the study prior to initiation. The fellows will be randomized on a daily basis to perform colonoscopies in a room. Outcomes will measure the effects of AI in fellows
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | AI use in Endoscopy Room | The use of AI versus no AI in comparing the detection of adenomas during Endoscopy procedures. |
| OTHER | Non-AI use Standard of Care endoscopy room | Non-AI use in comparing the detection of adenomas during Endoscopy procedures. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2025-06-01
- Completion
- 2025-09-01
- First posted
- 2022-06-21
- Last updated
- 2023-03-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05423964. Inclusion in this directory is not an endorsement.